Your browser doesn't support javascript.
loading
NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.
Eyre, Toby A; Clifford, Ruth; Bloor, Adrian; Boyle, Lucy; Roberts, Corran; Cabes, Maite; Collins, Graham P; Devereux, Stephen; Follows, George; Fox, Christopher P; Gribben, John; Hillmen, Peter; Hatton, Chris S; Littlewood, Tim J; McCarthy, Helen; Murray, Jim; Pettitt, Andrew R; Soilleux, Elizabeth; Stamatopoulos, Basile; Love, Sharon B; Wotherspoon, Andrew; Schuh, Anna.
Afiliación
  • Eyre TA; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
  • Clifford R; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
  • Bloor A; NIHR BRC Oxford Molecular Diagnostic Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
  • Boyle L; Department of Haematology, The Christie Hospital NHS Trust, Wimslow Road, Manchester, UK.
  • Roberts C; OCTO - Oncology Clinical Trials Office, Department of Oncology, University of Oxford, Oxford, UK.
  • Cabes M; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Collins GP; NIHR BRC Oxford Molecular Diagnostic Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
  • Devereux S; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
  • Follows G; Department of Haematology, Kings College Hospital, London, UK.
  • Fox CP; Department of Haematology, Addenbrooke's Hospital NHS Trust, Cambridge, UK.
  • Gribben J; Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Hillmen P; Institute of Cancer, Barts & the London School of Medicine & Dentistry, London, UK.
  • Hatton CS; St James's Institute of Oncology; Dena Cohen, University of Leeds, Leeds, UK.
  • Littlewood TJ; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
  • McCarthy H; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
  • Murray J; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Pettitt AR; Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK.
  • Soilleux E; Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, Merseyside, UK.
  • Stamatopoulos B; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Love SB; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Wotherspoon A; NIHR BRC Oxford Molecular Diagnostic Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
  • Schuh A; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
Br J Haematol ; 175(1): 43-54, 2016 Oct.
Article en En | MEDLINE | ID: mdl-27378086
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: Br J Haematol Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Revista: Br J Haematol Año: 2016 Tipo del documento: Article